Company
Braveheart Bio, Inc.
Braveheart Bio, Inc. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| BHB-1893 | Phase 3 | Cardiomyopathy, Hypertrophic Obstructive |
Latest
Follow Braveheart Bio, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.